The prevalence of cardiovascular risk factors and diabetes increases with a body mass index of ≥23 kg/m2in filipino american women

Ethnicity and Disease

Volumn 24, Issue 1, 2014, Pages 48-54

  Ancheta, Irma B ^a   Battie, Cynthia A ^a   Tuason, Ma Teresa ^a   Borja Hart, Nancy ^b   Ancheta, Christine V ^c  

^a UNIVERSITY OF NORTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Asian; Cardiovascular risk factors; Diabetes; Filipino; Minority; Women

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ETHNIC GROUP; FEMALE; FILIPINO AMERICAN; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; RISK FACTOR; SCREENING TEST; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; ETHNIC GROUPS; FEMALE; HUMANS; MIDDLE AGED; PHILIPPINES; PREVALENCE; RISK FACTORS;

EID: 84893517171     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Republic of the Philippines Department of Health. Leading Causes of Mortality. www.doh.gov.ph/node/198.html. Accessed October 29, 2013.
2. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125(1): e2-e220.
3. Wang EJ, Wong EC, Dixit AA, Fortmann SP, Linde RB, Palaniappan LP. Type 2 diabetes: identifying high risk Asian American subgroups in a clinical population. Diabetes Res Clin Pract. 2011;93(2):248-254.
4. Palaniappan LP, Wong EC, Shin JJ, Fortmann SP, Lauderdale DS. Asian Americans have greater prevalence of metabolic syndrome despite lower body mass index. Int J Obes (Lond). 2011;35(3):393-400.
5. Holland AT, Wong EC, Lauderdale DS, Palaniappan LP. Spectrum of cardiovascular diseases in Asian-American racial/ethnic subgroups. Ann Epidemiol. 2011;21(8):608-614.
6. Araneta MR, Barrett-Connor E. Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and White women. Obes Res. 2005;13(8):1458-1465.
7. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation . 2011;123(11): 1243-1262.
8. Deurenberg-Yap M, Schmidt G, van Staveren WA, Deurenberg P. The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord. 2000;24(8):1011-1017. (Pubitemid 30618121)
9. Wen CP, David Cheng TY, Tsai SP, et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr. 2009; 12(4):497-506.
10. Pan WH, Flegal KM, Chang HY, Yeh WT, Yeh CJ, Lee WC. Body mass index and obesity-related metabolic disorders in Taiwanese and US Whites and Blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr. 2004;79(1):31-39. (Pubitemid 41132059)
11. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157-163.
12. Low S, Chin MC, Ma S, Heng D, Deurenberg-Yap M. Rationale for redefining obesity in Asians. Ann Acad Med Singapore. 2009; 38(1):66-69.
13. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev. 2005;13(6):322-327. (Pubitemid 41579599)
14. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36 Suppl 1:S67-S74.
15. American Diabetes Association. Living with diabetes: A1C. www.diabetes.org/living-withdiabetes/treatment-and-care/blood-glucosecontrol/ a1c/. Accessed October 29, 2013.
16. US Department of Health and Human Services. The Seventh Report of the Joint National Committee on Prevention, Detection Evaluation, and Treatment of High Blood Pressure. 2004.
17. International Diabetes Foundation. The IDF consensus worldwide definition of the Metabolic Syndrome. 2006. www.idf.org/webdata/docs/IDF-Meta-def-final. pdf. Accessed October 29, 2013.
18. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3): 499-511. (Pubitemid 36158056)
19. World Health Organization. Cardiovascular Diseases. www.who.int/ mediacentre/factsheets/ fs317/en/. Accessed July 28, 2013.
20. Center for Disease Control and Prevention. About BMI for Adults. www.cdc.gov/healthy weight/assessing/bmi/adult-bmi/index.html. Accessed July 28, 2013.
21. Prentice AM, Jebb SA. Beyond body mass index. Obes. Rev 2001;2:141-147. (Pubitemid 33755907)
22. Deurenberg P, Deurenberg-Yap M. Validity of body composition methods across ethnic population groups. Forum Nutr. 2003;56: 299-301.
23. Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol. 1996;143:228-239. (Pubitemid 26032628)
24. He M, Tan KC, Li ET, Kung AW. Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese. Int J Obes Relat Metab Disord. 2001;25: 748-752. (Pubitemid 32417647)
25. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Consultation. WHO Technical Report Series Number 854. Geneva: World Health Organization, 1995.
26. Holland AT, Zhao B, Wong EC, Choi SE, Wong ND, Palaniappan LP. Racial/ethnic differences in control of cardiovascular risk factors among type 2 diabetes patients in an insured, ambulatory care population. J Diabetes Complications. 2013;27(1):34-40.
27. Karter AJ, Schillinger D, Adams AS, et al. Elevated rates of diabetes in Pacific Islanders and Asian Subgroups: The Diabetes Study of Northern California (DISTANCE). Diabetes Care. 2013;36(3):574-579.
28. Gentilucci UV, Picardi A, Manfrini S, M et al. Westernization of the Filipino population resident in Rome: obesity, diabetes and hypertension. Diabetes Metab Res Rev. 2008;24(5):364-370.
29. Ancheta IB, Battie CA, Tuason T, Ancheta CV. A comparison of metabolic syndrome (MetS) risk factors in Filipino women and Filipino American women: a pilot study. Ethn Dis. 2012;22(4):404-409.
30. Ye J, Rust G, Baltrus P, Daniels E. Cardiovascular risk factors among Asian Americans: results from a National Health Survey. Ann Epidemiol. 2009;19(10):718-723.
31. Ridker PM. Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates? Curr Atheroscler Rep. 2013;15(1):295.
32. Ganguli D, Das N, Saha I, et al. Association between inflammatory markers and cardiovascular risk factors in women fromKolkata,W.B., India. Arq Bras Cardiol. 2011;96(1):38-46.
33. Ridker PM, Fonseca FA, Genest J, et al. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. Am J Cardiol. 2007;100(11):1659-1664. (Pubitemid 350122337)
34. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-2207.
35. Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2004;109(7):837-842. (Pubitemid 38252734)